✦ LIBER ✦

987 Peginterferon alfa-2A (40KD) (PEGASYS®) and ribavirin (COPEGUS®) in patients with HIV/HCV coinfection: interim results of a randomized, multicenter study from spain

✍ Scribed by HERNANDEZQUERO, J; PEREZGUZMAN, E; LOZANO, F; PARRA, J; DELMARALONSO, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

497 An open-label, multicenter study of

✍ E. Ortega; A. Martin; C. Barros; K. Aguirrebengoa; J. Gonzalez; A. Garcia; R. Ru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

82 Further reduction of ribavirin dose i

✍ P. Ferenci; H. Brunner; H. Laferl; U. Bergholz; M. Rosenbeiger; R. Stauber; A. M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 122 KB

106 International, multicenter, randomiz

✍ Stefan Zeuzem; Moisés Diago; Edward Gane; Rajender Reddy; Paul Pockros; Patrizia 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

507 Early prediction of sustained virolo

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

1207 High-dose peginterferon alfa-2A (40

✍ DIAGO, M; ROMEROGOMEZ, M; DEVALME, H; CRESPO, J; VALDECILLA, H; OLVEIRA, A; LAPA 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

187 Efficacy and safety of 22 weeks of m

✍ Jean-Pierre Bronowicki; Denis Ouzan; Arnaud Tzanck; Tarik Asselah; Herve Desmora 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB